HERON THERAPEUTICS, INC. /DE/ Net Cash Provided by (Used in) Investing Activities, Continuing Operations
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$42.51 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-09
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $2.41M, a 87.02% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$44.92M, a 298.25% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was $18.56M.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $22.66M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month |
|---|---|---|
| 2017-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$42.51M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$44.92M 10-Q · filed 2017-05-10 | |
| 2016-06-30 | $18.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $41.22M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $22.66M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |